PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 10,529 shares of PACS Group stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $45.23, for a total value of $476,226.67. Following the completion of the sale, the chief executive officer owned 54,555,566 shares of the company’s stock, valued at $2,467,548,250.18. The trade was a 0.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51.
- On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total transaction of $396,098.36.
- On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total transaction of $206,164.14.
- On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total transaction of $1,046,238.93.
- On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The shares were sold at an average price of $42.69, for a total value of $984,943.68.
- On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The stock was sold at an average price of $42.56, for a total value of $858,562.88.
- On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The stock was sold at an average price of $42.94, for a total value of $1,021,242.02.
- On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The stock was sold at an average price of $42.39, for a total value of $1,024,015.23.
- On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The shares were sold at an average price of $43.90, for a total value of $2,600,811.60.
- On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The shares were sold at an average price of $43.92, for a total value of $4,010,159.52.
PACS Group Stock Performance
NYSE:PACS traded down $0.15 on Monday, hitting $44.61. The stock had a trading volume of 759,862 shares, compared to its average volume of 904,574. The business’s 50-day simple moving average is $44.74 and its two-hundred day simple moving average is $39.08. The stock has a market cap of $7.06 billion, a price-to-earnings ratio of 25.93, a price-to-earnings-growth ratio of 1.40 and a beta of -0.13. PACS Group, Inc. has a 52-week low of $9.69 and a 52-week high of $49.49. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. Tidal Investments LLC bought a new position in PACS Group in the 2nd quarter worth $252,000. Engineers Gate Manager LP purchased a new position in shares of PACS Group in the second quarter valued at about $1,132,000. Integrated Wealth Concepts LLC purchased a new position in shares of PACS Group in the second quarter valued at about $75,000. Squarepoint Ops LLC boosted its stake in shares of PACS Group by 94.7% in the second quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock worth $2,538,000 after acquiring an additional 28,945 shares during the period. Finally, Nykredit A S bought a new position in shares of PACS Group in the second quarter worth about $95,000.
Analyst Upgrades and Downgrades
PACS has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their price objective on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. Zacks Research downgraded PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Weiss Ratings lowered PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th. Oppenheimer upped their price target on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, Truist Financial set a $62.00 price objective on PACS Group in a research note on Wednesday, September 2nd. Five investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $58.80.
Read Our Latest Report on PACS
PACS Group Company Profile
PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.
The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.
Recommended Stories
- Five stocks we like better than PACS Group
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
